Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 674

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

Open access
Laaksonen, Reijo, Ekroos, Kim, Sysi-Aho, Marko, Hilvo, Mika, Vihervaara, Terhi, Kauhanen, Dimple, Suoniemi, Matti, Hurme, Reini, März, Winfried, Scharnagl, Hubert, Stojakovic, Tatjana, Vlachopoulou, Efthymia, Lokki, Marja-Liisa, Nieminen, Markku S., Klingenberg, Roland, Matter, Christian M., Hornemann, Thorsten, Jüni, Peter, Rodondi, Nicolas, Räber, Lorenz, Windecker, Stephan, Gencer, Baris, Pedersen, Eva Ringdal, Tell, Grethe S., Nygård, Ottar, Mach, Francois, Sinisalo, Juha, Lüscher, Thomas F.·2016·European Heart Journal

Abstract

AIMS: The aim was to study the prognostic value of plasma ceramides (Cer) as cardiovascular death (CV death) markers in three independent coronary artery disease (CAD) cohorts. METHODS AND RESULTS: Corogene study is a prospective Finnish cohort including stable CAD patients (n = 160). Multiple lipid biomarkers and C-reactive protein were measured in addition to plasma Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:0), and Cer(d18:1/24:1). Subsequently, the association between high-risk ceramides and CV mortality was investigated in the prospective Special Program University Medicine-Inflammation in Acute Coronary Syndromes (SPUM-ACS) cohort (n = 1637), conducted in four Swiss university hospitals. Finally, the results were validated in Bergen Coronary Angiography Cohort (BECAC), a prospective Norwegian cohort study of stable CAD patients. Ceramides, especially when used in ratios, were significantly associated with CV death in all studies, independent of other lipid markers and C-reactive protein. Adjusted odds ratios per standard deviation for the Cer(d18:1/16:0)/Cer(d18:1/24:0) ratio were 4.49 (95% CI, 2.24-8.98), 1.64 (1.29-2.08), and 1.77 (1.41-2.23) in the Corogene, SPUM-ACS, and BECAC studies, respectively. The Cer(d18:1/16:0)/Cer(d18:1/24:0) ratio improved the predictive value of the GRACE score (net reclassification improvement, NRI = 0.17 and ΔAUC = 0.09) in ACS and the predictive value of the Marschner score in stable CAD (NRI = 0.15 and ΔAUC = 0.02). CONCLUSIONS: Distinct plasma ceramide ratios are significant predictors of CV death both in patients with stable CAD and ACS, over and above currently used lipid markers. This may improve the identification of high-risk patients in need of more aggressive therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw148

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 674

Metadata

Authors
Laaksonen, R., Ekroos, K., Sysi-Aho, M., Hilvo, M., Vihervaara, T., Kauhanen, D., Suoniemi, M., Hurme, R., März, W., Scharnagl, H., Stojakovic, T., Vlachopoulou, E., Lokki, M.-L., Nieminen, M. S., Klingenberg, R., Matter, C. M., Hornemann, T., Jüni, P., Rodondi, N., Räber, L., Windecker, S., Gencer, B., Pedersen, E. R., Tell, G. S., Nygård, O., Mach, F., Sinisalo, J., & Lüscher, T. F.
Venue
European Heart Journal
Published
2016-04-28
Volume
37
Issue
25
Pages
1967-1976
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2344273352
Cited by
674
References
32
FWCI
18.66
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. https://app.cochat.ai/papers/10.1093/eurheartj/ehw148
The paper
Laaksonen, R., Ekroos, K., Sysi-Aho, M., Hilvo, M., Vihervaara, T., Kauhanen, D., Suoniemi, M., Hurme, R., März, W., Scharnagl, H., Stojakovic, T., Vlachopoulou, E., Lokki, M.-L., Nieminen, M. S., Klingenberg, R., Matter, C. M., Hornemann, T., Jüni, P., Rodondi, N., . . . Lüscher, T. F. (2016). Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.